More Articles – ARDS, HPC Updates, Statins
More Tags – ,
A new randomized controlled trial out of the UK that investigated 540 patients with ARDS from sepsis showed no benefit of statins.  The study investigated the use of Simvastatin 80 mg/day vs placebo in patients with ARDS from sepsis and…
Read More
Preface: The SPARCL trial made clinicians wary that high-dose statins may increase the risk of intracranial hemorrhage (ICH). This new observational study suggests that continued statin use after ICH appears to improve outcomes. The SPARCL trial (Stroke Prevention through Aggressive Reduction…
Read More
Menu